Image pharmaphorum Editor News Evotec and Celgene unite to drive forward oncology R&D Evotec and Celgene have joined forces in a long-term strategic drug discovery and development partnership, to identify new therapeutics in oncology. News May champions AI-backed R&D into cancer and chronic disease Theresa May has pledged to prioritise artificial intelligence (AI) so chronic diseases are diagnosed at an early stage, potentially saving many lives. News SMEs: the next generation of pharma News Patient-centricity in RWE: fine words, fiction or facts? The perennial challenge for pharmaceutical companies that espouse a patient-centric approach to their activities is being able to prove that they can ‘walk the talk’ when it comes to being closer t Load more results
News Evotec and Celgene unite to drive forward oncology R&D Evotec and Celgene have joined forces in a long-term strategic drug discovery and development partnership, to identify new therapeutics in oncology.
News May champions AI-backed R&D into cancer and chronic disease Theresa May has pledged to prioritise artificial intelligence (AI) so chronic diseases are diagnosed at an early stage, potentially saving many lives.
News Patient-centricity in RWE: fine words, fiction or facts? The perennial challenge for pharmaceutical companies that espouse a patient-centric approach to their activities is being able to prove that they can ‘walk the talk’ when it comes to being closer t
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
